Some of it can come from lean muscle mass, which is a concern that becomes especially important during menopause, when maintaining muscle is already more challenging
Zepbound (tirzepatide) is an FDA-approved medication for chronic weight management that works through dual GIP and GLP-1 receptor activation
The most common adverse effects of tirzepatide are gastrointestinal, including nausea (occurring in 20-30% of patients), diarrhea, vomiting, constipation, and abdominal discomfort
Left unaddressed, OSA can significantly impair daily functioning, affecting both cognitive performance and overall quality of life, necessitating effective management strategies
When to consider switching between medications Sometimes the best response to intolerable side effects is not pushing through
In summary, TZP was greater to semaglutide in reducing HbA 1c (71)